Select Medical Holdings (SEM) Capital Expenditures (2018 - 2026)

Select Medical Holdings (SEM) has 9 years of Capital Expenditures data on file, last reported at $58.9 million in Q1 2026.

• Quarterly Capital Expenditures rose 12.53% year-over-year to $58.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $235.8 million (up 991.29% YoY) and the FY2025 annual result came in at $229.2 million, up 952.26% from the prior year.
• Capital Expenditures steadied at $58.9 million in Q1 2026 per SEM's latest filing, from $59.1 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $64.7 million in Q2 2025 and bottomed at -$137.0 million in Q4 2024.
• The 5-year median for Capital Expenditures is $53.1 million (2025), against an average of $42.9 million.
• The widest annual swing landed in 2024, when Capital Expenditures tumbled 326.0%; it then soared 143.15% in 2025.
• Tracing SEM's Capital Expenditures over 5 years: stood at $55.3 million in 2022, then climbed by 9.68% to $60.6 million in 2023, then plunged by 326.0% to -$137.0 million in 2024, then soared by 143.15% to $59.1 million in 2025, then decreased by 0.34% to $58.9 million in 2026.
• Per Business Quant, the three latest SEM Capital Expenditures figures stand at $58.9 million (Q1 2026), $59.1 million (Q4 2025), and $53.1 million (Q3 2025).

Peer Comparison